Aerocrine: Interim Report January - March 2013

Published: May 07, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Aerocrine (STO:AERO-B) secures long-term financing. US clinical sales grew by 45%.

January – March 2013

•Global Net sales decreased by 14% to SEK 33.7m (39.0)*. Adjusted for currency fluctuations, net sales decreased by 10% Year over Year (Y-o-Y).

Help employers find you! Check out all the jobs and post your resume.

Back to news